Scarica l'app Stockscreener
112.68
1.09%
1.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio - GuruFocus
EXACT SCIENCES CORP SEC 10-K Report - TradingView
ABT.SW Abbott Laboratories (SIX) volume spike 40x avg: watch CHF100.00 support - Meyka
Abbott Laboratories $ABT Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Krilogy Financial LLC Acquires Shares of 9,560 Abbott Laboratories $ABT - MarketBeat
Freemont Management S.A. Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next? - 24/7 Wall St.
DexCom earnings up next: Can G7 rollout offset Abbott competition? By Investing.com - Investing.com Nigeria
DexCom earnings up next: Can G7 rollout offset Abbott competition? - Investing.com
Abbott Labs: The healthcare dividend stock I'd happily hold forever - MSN
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever - AOL.com
Illinois Municipal Retirement Fund Has $22.46 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Cibc World Market Inc. Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Caisse Des Depots ET Consignations Buys 9,374 Shares of Abbott Laboratories $ABT - MarketBeat
‘Time to Buy,’ Says Options Trader Following Abbott’s (ABT) Earnings Implosion - TipRanks
Rhumbline Advisers Sells 57,100 Shares of Abbott Laboratories $ABT - MarketBeat
Jensen Investment Management Inc. Has $322.72 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Drug of Abuse Testing Market Is Going to Boom |• Abbott - openPR.com
ING Groep NV Has $63.40 Million Holdings in Abbott Laboratories $ABT - MarketBeat
US Says Abbott Lied, Must Repay Funds Spent On Formula - Law360
Exact Sciences Faces Shareholder Lawsuits Over Abbott Merger - TipRanks
Abbott stock rises on AFib device data buzz as traders weigh FDA overhang - Bez Kabli
Abbott Laboratories price tries to correct main downward trendForecast today10-02-2026 - Economies.com
After a 15% Drop, Is Abbott Stock Set Up for a Comeback in 2026? - TIKR.com
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Wealthfront Advisers LLC Reduces Stock Position in Abbott Laboratories $ABT - MarketBeat
Johnson Investment Counsel Inc. Has $130.71 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
S&CO Inc. Sells 16,992 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Rockland Trust Co. - MarketBeat
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine - MedTech Dive
Candriam S.C.A. Boosts Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by ProShare Advisors LLC - MarketBeat
Assessing Abbott Laboratories (ABT) Valuation After New AFib Catheter And Pulsed Field Ablation Data - simplywall.st
Diamond Hill Capital Management Inc. Sells 309,225 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating - Finviz
Alps Advisors Inc. Acquires 82,455 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott stock price: what to watch Monday after FDA Libre recall update, insider buy - TechStock²
Analysts’ Top Healthcare Picks: Mettler-Toledo (MTD), Abbott Laboratories (ABT) - The Globe and Mail
Insider Stock Buying Reaches US$3.10m On Abbott Laboratories - Yahoo Finance
Canada Post Corp Registered Pension Plan Purchases 94,730 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Lessened by Twin Capital Management Inc. - MarketBeat
Top Abbott Insider Quietly Makes a Bold Million-Dollar Move - TipRanks
Abbott Labs CEO makes $2M bet as stock sinks - thestreet.com
Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro - PRWeb
Exact Sciences (EXAS) Advances as HSR Period Expires for Abbott Deal - GuruFocus
Abbott Laboratories (NYSE:ABT) Director Daniel Starks Purchases 10,000 Shares - MarketBeat
William Blair Maintains Abbott Laboratories(ABT.US) With Buy Rating - 富途牛牛
Abbott studies support pulsed field ablation, dual ablation catheters - MassDevice
Abbott Stock: 2026 Recovery Outlook After a 17% Decline - TIKR.com
Abbott (ABT) Showcases Promising AFib Therapy Advances at Boston Symposium - GuruFocus
Abbott reports positive results from study on its atrial fibrillation therapies - AlphaStreet News
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Abbott’s atrial fibrillation treatments show strong results in new studies By Investing.com - Investing.com India
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135 - 富途牛牛
Abbott Labs director Starks buys shares worth $1.08 million By Investing.com - Investing.com Nigeria
Abbott Labs director Starks buys shares worth $1.08 million - Investing.com
Catheter trials show Abbott devices cut AFib episodes for most patients - Stock Titan
Aurdan Capital Management LLC Lowers Stake in Abbott Laboratories $ABT - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Lowers Position in Abbott Laboratories $ABT - MarketBeat
UK’s NICE recommends Abbott’s Cardiomems heart failure system - BioWorld MedTech
Abbott on track with dual sensor, FDA warns on FreeStyle Libre - Modern Healthcare News
BTIG Reaffirms Their Buy Rating on Abbott Laboratories (ABT) - The Globe and Mail
Abbott Laboratories $ABT Position Raised by Border to Coast Pensions Partnership Ltd - MarketBeat
Bessemer Group Inc. Purchases 10,684 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Homestead Advisers Corp - MarketBeat
Abbott Laboratories $ABT Shares Bought by Savant Capital LLC - MarketBeat
0.05%
1.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):